AXIN has been identified with mutations in various carcinoma types including hepatocellular carcinoma (HCC), CRC, medulloblastomas, and ovarian endometrioid adenocarcinoma [86–91]. This evidence concerns the gene AXIN1 and colorectal carcinoma.